Post-COVID Conditions Are Common Among Adult Survivors
More than 2-fold risk of acute pulmonary embolism and respiratory signs and symptoms among survivors aged 18 to 64, ≥65 years
More than 2-fold risk of acute pulmonary embolism and respiratory signs and symptoms among survivors aged 18 to 64, ≥65 years
Hospital research publications linked to lower risk-adjusted mortality rates for several conditions and procedures, higher patient satisfaction
New US study will assess the updated, omicron-targeted vaccine for use as a booster or for primary vaccinations
Masks already set up for distribution at some Hy-Vee and Meijer grocery stores in the Midwest
Treatments made by Regeneron and Eli Lilly performed well against earlier variants, but not against omicron
But protection against COVID-19 hospitalization, death after 2 doses of BNT162b2 or CHAdOx1-S is more durable
Doctors, health systems are in the difficult position of rationing supplies to meet the needs of those in the most dire situations
Surge in cases has overwhelmed hospitals nationwide, and about one-quarter face critical staffing shortages
Data show 4249 reports of adverse events after about 8.7 million doses of vaccine were administered; 97.6% not serious
Three-day course of treatment results in reduced risk for hospitalization or death compared with placebo